Hennion & Walsh Asset Management, Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,054,915
+32630.8%
126,186
-2.8%
0.07%
-64.9%
Q2 2023$3,223
+62.8%
129,756
-1.4%
0.19%
+57.9%
Q1 2023$1,980
+23.6%
131,628
-2.8%
0.12%
+22.2%
Q4 2022$1,602
-99.9%
135,442
-33.5%
0.10%
+25.3%
Q3 2022$1,205,000
+49.5%
203,582
+7.3%
0.08%
+58.0%
Q2 2022$806,000
-34.6%
189,669
+46.4%
0.05%
-23.1%
Q1 2022$1,232,000
-45.0%
129,520
+9.8%
0.06%
-40.9%
Q4 2021$2,241,000
-35.1%
117,935
+13.6%
0.11%
-39.6%
Q3 2021$3,455,000
-16.1%
103,814
-2.2%
0.18%
-16.9%
Q2 2021$4,116,000
-6.6%
106,103
+16.0%
0.22%
-17.4%
Q1 2021$4,408,00091,4550.26%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders